FeesSafety
Pluang+

Four large crypto transfers worth $637.6M occurred in three hours, mostly Bitcoin and Tether to Bitfinex.

Market News
08 Nov 2026, 22:03 WIB
Tokenpost
View Source
Neutral
Four large crypto transfers worth $637.6M occurred in three hours, mostly Bitcoin and Tether to Bitfinex.

Within a three-hour window ending Nov. 6 at 4:01 p.m. ET, four major cryptocurrency transfers totaling $637.6 million took place. The largest were two Bitcoin transfers between unknown wallets, moving 3,543 BTC ($268.9M) and 2,022 BTC ($153.3M). Additionally, two transfers of Tether (USDT) totaling $215.4 million were sent to the Bitfinex exchange. While deposits to exchanges can indicate potential selling, no outflows from exchanges were observed, and the Bitcoin transfers did not involve exchanges, leaving the intent unclear.

Bitcoin transfer activity is the subject, with $637.6 million moved in four major crypto transfers. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 09, 2026 02:21 WIB: out of 50 major cryptocurrencies, 8 rose and 41 fell. Notable movers include BAL at Rp16.297 (+11.14%), EOS at Rp12.649 (+8.13%), and EGLD at Rp53.931 (-5.11%) with 100% buy order activity on Pluang.

More News

NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.

NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.

NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...

Market News
Neutral
22 minutes ago
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
Bullish
4 hours ago
Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
Bullish
4 hours ago
3 stocks with recurring revenue face challenges but offer long-term growth potential.

3 stocks with recurring revenue face challenges but offer long-term growth potential.

Three companies—Otis Worldwide, Rollins, and Republic Services—offer recurring revenue through essential services like elevator maintenance, pest control, and waste management. Despite their steady cash flows and customer loyalty, Otis and Rollins fa...

Market News
Neutral
5 hours ago
Lawsuit probes J.B. Hunt for allegedly misleading investors after Q3 earnings warning

Lawsuit probes J.B. Hunt for allegedly misleading investors after Q3 earnings warning

Rosen Law Firm is investigating J.B. Hunt Transport Services for possibly providing misleading business information to investors after the company warned of a Q3 earnings decline. The firm's shares dropped sharply following a CNBC report about increa...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App